Profile data is unavailable for this security.
About the company
ZHEJIANG SHENGDA BIO-PHARM CO., LTD. is a China-based company principally engaged in the research, development, production and sales of vitamins and biological preservatives. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)742.96m
- Net income in CNY-53.74m
- Incorporated1999
- Employees1.03k
- LocationZhejiang Shengda Bio-Pharm Co LtdNo.789, Renmin East Road, Tiantai CountyTAIZHOU 317200ChinaCHN
- Phone+86 57 683966211
- Fax+86 57 683966111
- Websitehttps://www.sd-pharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Shengda Bio-pharm Co Ltd | 742.96m | -53.74m | 1.91bn | 1.03k | -- | 1.53 | -- | 2.57 | -0.3325 | -0.3325 | 4.27 | 7.31 | 0.4409 | 2.33 | 6.08 | 719,919.20 | -3.10 | 3.39 | -3.71 | 4.42 | 15.03 | 28.58 | -7.02 | 7.57 | 1.41 | -- | 0.2268 | 39.98 | -1.44 | 8.10 | -271.70 | -- | 11.22 | -6.89 |
| Jiangsu gdk Biotechnology Co Ltd | 33.39m | -128.83m | 2.05bn | 451.00 | -- | 1.52 | -- | 61.43 | -1.04 | -1.04 | 0.2686 | 10.95 | 0.0193 | 0.4185 | 0.1529 | 74,034.57 | -7.45 | 3.30 | -8.73 | 4.84 | 51.14 | 75.56 | -385.83 | 12.58 | 3.20 | -- | 0.048 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
| Shanghai Jiaoda Onlly Co Ltd | 280.54m | -39.86m | 2.06bn | 935.00 | -- | 7.07 | -- | 7.35 | -0.0514 | -0.0514 | 0.362 | 0.3761 | 0.3475 | 5.15 | 4.63 | 300,042.20 | -4.64 | -7.62 | -7.62 | -10.70 | 18.03 | 40.06 | -13.36 | -27.01 | 0.6301 | -1.40 | 0.3455 | -- | -21.43 | 2.65 | 92.96 | -- | -34.81 | -- |
| Shanghai Shen Lian Biomedical Corp | 281.44m | 25.86m | 2.14bn | 365.00 | 82.74 | 1.42 | -- | 7.60 | 0.063 | 0.063 | 0.6854 | 3.66 | 0.1731 | 0.7474 | 0.9025 | 771,056.40 | 1.54 | 6.85 | 1.65 | 7.54 | 70.64 | 79.21 | 8.92 | 29.63 | 6.58 | -- | 0.0008 | 30.78 | -8.32 | 1.70 | -44.56 | -9.14 | -2.08 | -- |
Data as of May 29 2024. Currency figures normalised to Zhejiang Shengda Bio-Pharm Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Galaxy Asset Management Co., Ltd.as of 31 Dec 2023 | 211.35k | 0.32% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 180.00k | 0.28% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 165.50k | 0.25% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 63.40k | 0.10% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 15.70k | 0.02% |
| Fortune & Royal Asset Management Co., Ltd.as of 31 Dec 2023 | 10.00k | 0.02% |
| SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 4.90k | 0.01% |
| Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 1.00k | 0.00% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 1.00k | 0.00% |
| Sealand Securities Co., Ltd. (Investment Management)as of 31 Dec 2023 | 200.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.
